Moderna Forging Ahead with mRNA Vaccine Programs for Difficult Viruses; CMV, HIV Jabs in Pipeline: CSO

Moderna Chief Scientific Officer Melissa Moore at Interview in Tokyo Moderna is pursing work on combination vaccines and difficult-to-develop jabs by harnessing the power of mRNA technology to simultaneously create multiple proteins in the human body. “There are something like...read more